Neuropathology of Cognitive Dysfunction in Multiple Sclerosis

Handbook of Clinical Neurology

Volumn 89, Issue , 2008, Pages 719-723

  Kutzelnigg, Alexandra ^a   Lassmann, Hans ^a  

^a Medical University of Vienna   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN; COGNITIVE DEFECT; HUMAN; MULTIPLE SCLEROSIS; PATHOLOGY; REVIEW;

BRAIN; COGNITION DISORDERS; HUMANS; MULTIPLE SCLEROSIS;

EID: 66049115803     PISSN: 00729752     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0072-9752(07)01264-X     Document Type: Review

References (39)

1. Amato M.P., Ponziani G., Siracusa G., et al. Cognitive dysfunction in early onset multiple sclerosis: a reappraisal after 10 years. Arch Neurol 58 (2001) 1602-1606
2. Archibald C.J., Wei X., Scott J.N., et al. Posterior fossa lesion volume and slowed information processing in multiple sclerosis. Brain 127 (2004) 1526-1534
3. Audoin B., Ranjeva J.P., My Van A.D., et al. Voxel-baed analyis of MTR images: a method to locate gray matter abnormalities in patients at the earliest stage of multiple sclerosis. J Magn Reson Imaging 20 (2004) 765-771
4. Audoin B., Ibarrola D., Au Duong M.V., et al. Functional MRI study of PASAT in normal subjects. MAGMA 18 (2005) 96-102
5. Au-Duong M.V., Boulanouar K., Audoin B., et al. Modulation of effective connectivity inside the working memory network in patients at the earliest stage of multiple sclerosis. Neuroimage 15 (2005) 533-538
6. Berg D., Maurer M., Warmuth-Metz M., et al. The correlation between ventricular diameter measured by transcranial sonography and clinical disability and cognitive dysfunction in patients with multiple sclerosis. Arch Neurol 57 (2000) 1289-1292
7. Bjartmar C., and Trapp B.D. Axonal and neuronal degeneration in multiple sclerosis: mechanisms and functional consequences. Curr Opin Neurol 14 (2001) 271-278
8. Callanan M.M., Logsdail S.J., Ron M.A., et al. Cognitive impairment in patients with clinically isolated lesions of the type seen in multiple sclerosis. A psychometric and MRI study. Brain 112 (1989) 361-374
9. Camp S.J., Stevenson V.L., Thompson A.J., et al. Cognitive function in primary progressive and transitional progressive multiple sclerosis: a controlled study with MRI correlates. Brain 122 (1999) 1341-1348
10. Charcot J.M. In: Delahaye A., and Lecrosnier E. (Eds). Lecons sur les Maladies du Systeme Nerveux faites a la Salpetriere (1872), Progres Medicale, Paris 1-495
11. Christodoulou C., Krupp L.B., Liang Z., et al. Cognitive performance and MRI markers of cerebral injury in cognitively impaired MS patients. Neurology 60 (2003) 1793-1798
12. Comi G., Rovaris M., Falautano M., et al. A multiparametric MRI study of frontal lobe dementia in multiple sclerosis. J Neurol Sci 171 (1999) 135-144
13. Feinstein A., Kartsounis L.D., Miller D.H., et al. Clinically isolated lesions of the type seen in multiple sclerosis: a cognitive, psychiatric, and MRI follow up study. J Neurol Neurosurg Psychiatry 55 (1992) 869-876
14. Feinstein A., Ron M., and Thompson A. A serial study of psychometric and magnetic resonance imaging changes in multiple sclerosis. Brain 116 (1993) 569-602
15. Foong J., Rozewicz L., Davie C.A., et al. Correlates of executive function in multiple sclerosis: the use of magnetic resonance spectroscopy as an index of focal pathology. J Neuropsychiatry Clin Neurosci 11 (1999) 45-50
16. Geurts J.J., Bo L., Pouwels P.J., et al. Cortical lesions in multiple sclerosis: combined postmortem MR imaging and histopathology. Am J Neuroradiol 26 (2005) 572-577
17. Heaton R.K., Nelson L.M., Thompson D.S., et al. Neuropsychological findings in relapsing-remitting and chronic-progressive multiple sclerosis. J Consult Clin Psychol 53 (1985) 103-110
18. Hohol M.J., Guttmann C.R., Orav J., et al. Serial neuropsychological assessment and magnetic resonance imaging analysis in multiple sclerosis. Arch Neurol 54 (1997) 1018-1025
19. Jennekens-Schinkel A., Laboyrie P.M., Lanser J.B., et al. Cognition in patients with multiple sclerosis: After four years. J Neurol Sci 99 (1990) 229-247
20. Kutzelnigg A., and Lassmann H. Cortical demyelination in multiple sclerosis: a substrate for cognitive deficits?. J Neurol Sci 245 (2006) 123-126
21. Kutzelnigg A., Lucchinetti C.F., Stadelmann C., et al. Cortical demyelination and diffuse white matter injury in multiple sclerosis. Brain 128 (2005) 2705-2712
22. Kutzelnigg A., Faber-Rod J.C., Bauer J., et al. Widespread demyelination in the cerebellar cortex in multiple sclerosis. Brain Pathology 17 (2007) 38-44
23. Lassmann H., and Wekerle H. The pathology of multiple sclerosis. In: Compston (Ed). McAlpine's Multiple Sclerosis. 4th edn. (2006), Churchill Livingstone, London 557-600
24. Lazeron R.H., Langdon D.W., Filippi M., et al. Neuropsychological impairment in multiple sclerosis patients: the role of (juxta) cortical lesion on FLAIR. Mult Scler 6 (2000) 280-285
25. Lucchinetti C., Brück W., Parisi J., et al. Heterogeneity of multiple sclerosis lesions: Implications for the pathogenesis of demyelination. Ann Neurol 47 (2000) 707-717
26. McIntosh-Michaelis S.A., Roberts M.H., Wilkinson S.M., et al. The prevalence of cognitive impairment in a community survey of multiple sclerosis. Br J Clin Psychol 30 (1991) 333-348
27. Noseworthy J.H., Lucchinetti C., Rodriguez M., et al. Multiple sclerosis. N Engl J Med 343 (2000) 938-952
28. Peterson J.W., Bo L., Mork S., et al. Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions. Ann Neurol 50 (2001) 389-400
29. Peyser J.M., Edwards K.R., Poser C.M., et al. Cognitive function in patients with multiple sclerosis. Arch Neurol 37 (1980) 577-579
30. Peyser J.M., Rao S.M., LaRocca N.G., et al. Guidelines for neuropsychological research in multiple sclerosis. Arch Neurol 47 (1990) 94-97
31. Piras M.R., Magnano I., Canu E.D., et al. Longitudinal study of cognitive dysfunction in multiple sclerosis: neuropsychological, neuroradiological and neurophysiological findings. J Neurol Neurosurg Psychiat 74 (2003) 875-885
32. Rao S.M., Leo G.J., Bernardin L., et al. Cognitive dysfunction in multiple sclerosis I. Frequency, patterns and prediction. Neurology 41 (1991) 685-691
33. Ron M.A., Callanan M.M., and Warrington E.K. Cognitive abnormalities in multiple sclerosis: a psychometric and MRI study. Psychol Med 21 (1991) 59-68
34. Rovaris M., Filippi M., Minicucci L., et al. Cortical/subcortical disease burden and cognitive impairment in patients with multiple sclerosis. Am J Neuroradiol 21 (2000) 402-408
35. Serafini B., Rosicarelli B., Magliozzi R., et al. Detection of ectopic B-cell follicles with germinal centers in the meninges of patients with secondary progressive multiple sclerosis. Brain Pathol 14 (2004) 164-174
36. Smith K., and Lassmann H. The role of nitric oxide in multiple sclerosis. Lancet Neurol 1 (2002) 202-241
37. Trapp B.D., Peterson J., Ransohoff R.M., et al. Axonal transection in the lesions of multiple sclerosis. N Engl J Med 338 (1998) 278-285
38. Wilson C.J., Finch C.E., and Cohen H.J. Cytokines and cognition - the case for a head-to-toe inflammatory paradigm. J Am Geriatr Soc 50 (2002) 2041-2056
39. Zarei M., Chandran S., Compston A., et al. Cognitive presentation of multiple sclerosis: evidence for a cortical variant. J Neurol Neurosurg Psychiatry 74 (2003) 872-877